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Abstract
C23H16ClN5O, monoclinic, P21/c (no. 14), a= 10.0503(6) Å,
b= 17.5265(9) Å, c= 22.8763(16) Å, β= 91.554(6)°,
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V = 4028.1(4) Å3, Z= 8, Rgt(F)=0.0748, wRref(F2)=0.2274,
T= 296(2) K.
CCDC no.: 1896315
Table 1: Data collection and handling.
Crystal: Colourless needle
Size: 0.58×0.07×0.02 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 0.22 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.9°,>99%
N(hkl)measured, N(hkl)unique, Rint: 41529, 10169, 0.077
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 4311
N(param)refined: 541
Programs: CrysAlisPRO [1], SHELX [2, 3],
WinGX/ORTEP [4]
The asymmetric unit of the title crystal structure containing
two molecules is shown in the figure. Tables 1 and 2 con-
tain details on crystal structure and measurement conditions
and a list of the atoms including atomic coordinates and
displacement parameters.
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Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
C1 0.3890(3) 0.07595(17) 0.33409(14) 0.0516(8)
C2 0.2807(3) 0.16753(16) 0.37830(15) 0.0533(8)
C3 0.3989(3) 0.15107(17) 0.34998(15) 0.0576(9)
H3 0.469334 0.184128 0.343358 0.069*
C4 0.4836(3) 0.02830(16) 0.30237(14) 0.0505(8)
C5 0.6183(3) 0.03274(17) 0.31636(15) 0.0603(9)
H5 0.646981 0.066288 0.345563 0.072*
C6 0.7099(3) −0.01036(17) 0.28876(14) 0.0564(8)
H6 0.799750 −0.006717 0.299160 0.068*
C7 0.6675(4) −0.05933(18) 0.24531(15) 0.0589(9)
C8 0.5356(4) −0.0643(2) 0.22852(15) 0.0673(10)
H8 0.508679 −0.096643 0.198204 0.081*
C9 0.4436(4) −0.02083(19) 0.25713(14) 0.0626(9)
H9 0.354015 −0.024200 0.246218 0.075*
C10 0.2165(3) −0.02487(16) 0.35582(14) 0.0538(8)
C11 0.2939(4) −0.08255(17) 0.37802(15) 0.0640(9)
H11 0.381462 −0.073152 0.390111 0.077*
C12 0.2412(5) −0.15462(19) 0.38234(18) 0.0784(12)
H12 0.293765 −0.194014 0.397436 0.094*
C13 0.1129(5) −0.1692(2) 0.36478(18) 0.0812(12)
H13 0.077768 −0.218024 0.367998 0.097*
C14 0.0370(5) −0.1110(2) 0.3424(2) 0.0926(14)
H14 −0.050415 −0.120629 0.330133 0.111*
C15 0.0875(4) −0.03850(19) 0.33775(19) 0.0822(12)
H15 0.034962 0.000806 0.322538 0.099*
C16 0.2424(3) 0.24025(15) 0.40315(14) 0.0495(8)
C17 0.2760(3) 0.35460(16) 0.43067(14) 0.0503(8)
C18 0.3036(3) 0.49227(15) 0.44615(13) 0.0490(8)
C19 0.1756(3) 0.50888(17) 0.46167(15) 0.0580(9)
H19 0.114822 0.469972 0.468144 0.070*
C20 0.1384(4) 0.58543(18) 0.46756(14) 0.0639(9)
H20 0.051930 0.597136 0.477916 0.077*
C21 0.2266(4) 0.64335(18) 0.45840(15) 0.0634(10)
H21 0.200325 0.693980 0.461928 0.076*
C22 0.3542(4) 0.62560(17) 0.44396(15) 0.0653(10)
H22 0.415008 0.664674 0.438103 0.078*
C23 0.3941(4) 0.55106(17) 0.43797(14) 0.0603(9)
H23 0.481363 0.539981 0.428466 0.072*
C24 0.8949(3) 0.56743(16) 0.33028(13) 0.0498(8)
C25 0.7852(3) 0.47294(15) 0.37025(13) 0.0467(7)
C26 0.9011(3) 0.49075(16) 0.34127(14) 0.0547(8)
H26 0.968906 0.457402 0.331405 0.066*
C27 0.9924(3) 0.61734(15) 0.30187(13) 0.0507(8)
C28 1.1260(3) 0.60727(16) 0.31558(14) 0.0545(8)
H28 1.151888 0.569497 0.342073 0.065*
C29 1.2208(4) 0.65193(18) 0.29083(14) 0.0606(9)
H29 1.310318 0.644402 0.300424 0.073*
C30 1.1833(4) 0.70797(18) 0.25173(14) 0.0572(9)
C31 1.0515(4) 0.71792(19) 0.23610(15) 0.0686(10)
H31 1.026625 0.754689 0.208604 0.082*
C32 0.9560(4) 0.67289(18) 0.26153(15) 0.0626(9)
H32 0.866609 0.679994 0.251428 0.075*
C33 0.7327(3) 0.66869(16) 0.36177(14) 0.0538(8)
C34 0.7923(4) 0.70961(19) 0.40582(18) 0.0785(12)
H34 0.860665 0.688312 0.428654 0.094*
C35 0.7496(5) 0.7833(2) 0.4160(2) 0.1021(16)
H35 0.789406 0.812020 0.445878 0.123*
Table 2 (continued)
Atom x y z Uiso*/Ueq
C36 0.6488(5) 0.8138(2) 0.3822(2) 0.0916(14)
H36 0.620941 0.863560 0.388822 0.110*
C37 0.5894(5) 0.7721(2) 0.3392(2) 0.0909(14)
H37 0.520318 0.793112 0.316618 0.109*
C38 0.6310(4) 0.6986(2) 0.32887(18) 0.0773(11)
H38 0.589699 0.669661 0.299537 0.093*
C39 0.7431(3) 0.39879(15) 0.39055(13) 0.0464(7)
C40 0.7719(3) 0.28299(14) 0.41504(13) 0.0432(7)
C41 0.7971(3) 0.14847(15) 0.44222(13) 0.0469(7)
C42 0.6676(4) 0.13631(17) 0.45812(15) 0.0613(9)
H42 0.607118 0.176465 0.457657 0.074*
C43 0.6283(4) 0.06473(19) 0.47464(17) 0.0757(11)
H43 0.540876 0.056686 0.485467 0.091*
C44 0.7171(4) 0.00425(19) 0.47540(17) 0.0766(11)
H44 0.689683 −0.044051 0.486847 0.092*
C45 0.8442(4) 0.01608(19) 0.45932(18) 0.0752(11)
H45 0.904277 −0.024277 0.459469 0.090*
C46 0.8848(4) 0.08827(17) 0.44264(16) 0.0658(10)
H46 0.972141 0.096049 0.431630 0.079*
N1 0.2686(3) 0.05133(13) 0.35342(11) 0.0522(7)
N2 0.2005(3) 0.10730(13) 0.38100(12) 0.0570(7)
N3 0.1313(3) 0.26436(13) 0.42108(13) 0.0614(8)
N4 0.1515(3) 0.34066(13) 0.44056(13) 0.0591(7)
N5 0.3508(3) 0.41697(13) 0.43757(12) 0.0588(7)
H5A 0.435680 0.410948 0.436741 0.071*
N6 0.7773(3) 0.59160(13) 0.35255(11) 0.0523(7)
N7 0.7085(3) 0.53417(13) 0.37771(12) 0.0526(7)
N8 0.6283(3) 0.37335(12) 0.40348(11) 0.0492(6)
N9 0.6462(3) 0.29614(12) 0.42000(11) 0.0501(6)
N10 0.8453(3) 0.22012(12) 0.42502(11) 0.0518(7)
H10 0.929649 0.224014 0.420462 0.062*
O1 0.3407(2) 0.29346(10) 0.40777(10) 0.0539(6)
O2 0.84051(19) 0.34453(10) 0.39614(9) 0.0472(5)
Cl1 0.78374(11) −0.11647(6) 0.21089(5) 0.0868(4)
Cl2 1.30314(11) 0.76686(6) 0.22326(4) 0.0885(4)
Source of material
The title compound was synthesized from treatment
of 2-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazole-3-carbonyl)-
N-phenylhydrazinecarbothioamide with anhydrous sodium
acetate in boiling ethanol for 5 h. The solid obtained on cool-
ing the reaction mixture was filtered, washed with ethanol,
dried and crystallized from dimethylformamide to give color-
less crystals (63%) of the title compound, Mp. 238−240 °C.
Experimental details
H atoms were positioned geometrically and refined using a
riding model. U iso(H) for aromatic and N—H hydrogens were
set to 1.2 times Ueq for the atoms they are bonded to. Aro-
matic C—Hbondswere fixed at 0.93 Å andN—Hat 0.86 Å. The
weakly diffracting crystal yielded a wR2 factor slightly larger
than 20%. Nevertheless the data weren’t cut, as the strongest
of them may provide some information.
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Comment
Heterocycles containing the 1,3,4-oxadiazol-2-amine moiety
show different biological activities and act as anticancer and
antiproliferative agents [5–8]. Also, the pyrazole ring system
is the core of a number of drugs such as celecoxib, fezolamide
and difenamizole [9–11].
The asymmetric unit comprises two independent
molecules (see the figure). Themolecule consists of five rings:
phenyl (R1), oxadiazolyl (R2), pyraxolyl (R3), chlorophenyl
(R4) and a second phenyl (R5) ring linked to R3. The twist
angles between the planes of pairs of linked rings R1–R2,
R2–R3, R3–R4, R3–R5 are 17.54(11), 11.94(17), 43.54(12) and
52.49(10)° respectively for the first molecule (C1—C23) and
6.81(12), 18.80(13), 43.10(11) and 7844(11)° respectively for the
secondmolecule (C24—C46).Weak intramolecular contacts of
C—H· · ·N type involving phenyl and oxadiazolyl rings occur.
R22(9) rings due to N—H· · ·N and C—H· · ·N interactions
between neighbouring molecules lead to the formation of
ribbons parallel to [100].
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